PKM2 inhibitors (Agios/Celgene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePKM2 inhibitors (Agios/Celgene)
Drug Alias Namepyruvate kinase M2 inhibitors (Agios/Celgene)AGX-257
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate kinase isozymes M1/M2 inhibitors
TargetsPyruvate kinase isozymes M1/M2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgios Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene CorpAgios Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A